Journal of
AIDS and HIV Research

  • Abbreviation: J. AIDS HIV Res.
  • Language: English
  • ISSN: 2141-2359
  • DOI: 10.5897/JAHR
  • Start Year: 2009
  • Published Articles: 258

Full Length Research Paper

Barriers of adherence to antiretroviral therapy among HIV/AIDS infected persons in Nekemte referral Hospital, East Wollega, Oromia Regional State, Western Ethiopia, 2017

Kassahun Tegegne Bidu
  • Kassahun Tegegne Bidu
  • Primary Health Care Project, East Wollega Zone, Nekemte, Western Ethiopia.
  • Google Scholar
Zalalem Kaba Babure
  • Zalalem Kaba Babure
  • East Wollega Zonal Health Office, Nekemte, Western Ethiopia.
  • Google Scholar


  •  Received: 09 March 2018
  •  Accepted: 29 March 2018
  •  Published: 31 May 2018

References

Abera A, Fenti B, Tesfaye T, Balcha F (2015). Factors Influencing Adherence to Antiretroviral Therapy among People Living With HIV/AIDS at ART Clinic in Jimma University Teaching Hospital, Southwest Ethiopia. J. Pharm. Rep. 1(101):2.

 

Agwu AL, Fairlie L (2013). Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents. J. Int. AIDS Soc. 16:18579.
Crossref

 

Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K (2008). Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Public Health 8:265.
Crossref

 

Amico KR, Harman JJ, Johnson BT (2006). Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 41(3):285-297.
Crossref

 

Ankrah DN, Koster ES, Mantel-Teeuwisse AK, Arhinful DK, Agyepong IA, Lartey M (2016). Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana. Patient Prefer. Adherence 10:329-337.
Crossref

 

Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, Kassie DM (2014). Barriers and Facilitators of Adherence to Antiretroviral Drug Therapy and Retention in Care among Adult HIV-Positive Patients: A Qualitative Study from Ethiopia. PLoS One 9(5):e97353.
Crossref

 

Biadgilign S, Deribew A, Amberbir A, Escudero HR, Deribe K (2011). Factors Associated with HIV/AIDS Diagnostic Disclosure to HIV Infected Children Receiving HAART: A Multi-Center Study in Addis Ababa, Ethiopia. PloS one 6(3):e17572.
Crossref

 

Chindedza M, Mutseyekwa F, Chideme-Munodawafa A (2013). Perceived barriers to accessing and achieving adherence in antiretroviral therapy among HIV patients at a rural mission hospital in Zimbabwe. Eur. Scientific J. 9(24):277-287.

 

Cluver LD, Hodes RJ, Toska E, Kidia KK, Orkin FM, Sherr L, Meinck F (2015). HIV is like a tsotsi. ARVs are your guns': associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa. AIDS 29(Suppl 1):S57-S65.
Crossref

 

Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. (2008). Medication compliance and persistence: terminology and definitions. Value Health 11(1):44-47.
Crossref

 

Ethiopian Federal Ministry of Health (2012). Human immunodeficiency virus or Acquired immunodeficiency (HIV/AIDS) Prevention and Control office (HAPCO);Country progress report in HIV/AIDS response, Addis Ababa. 

 

Ethiopian Federal Ministry of Health HIV/AIDS Prevention and Control office (HAPCO) (2012). Country progress report in HIV/AIDS response. Addis Ababa: Ethiopian Federal Ministry of Health HIV/AIDS Prevention and Control office. 

 

Global Health Observatory (GHO) (2016). HIV/AIDS. 

View

 

Kasumu LO, Balogun MR (2014). Knowledge and attitude towards antiretroviral therapy and adherence pattern of HIV patients in southwest Nigeria. Int. J. Infect. Control 10(3):1-8.

 

Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, Tsai AC (2013). Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J. Int. AIDS Soc. 16(3 Suppl 2):18640.
Crossref

 

Meresse M, March L, Kouanfack C, Bonono RC, Boyer S, Laborde‐Balen G, Aghokeng A, Suzan‐Monti M, Delaporte E, Spire B, Carrieri MP (2014). Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Strat all ANRS 12110/ESTHER trial in Cameroon. HIV Med. 15(8):478-487.
Crossref

 

Millennium Development Goals (MDGs) (2015). Millennium Development Goals: Country report 2015 / Statistics South Africa.

 

Pretoria: Statistics South Africa, 2015. 

View

 

Mohammed AY, Ahmed MB, Tefera TB (2015). Assessment of Factors Affecting Art Adherence among People Living with Human Immune Virus in Bale Robe Hospital, South East Ethiopia. Am. J. Public Health 3(2):60-67.

 

Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G (2006). Adherence to Highly Active Antiretroviral Therapy Assessed by Pharmacy Claims Predicts Survival in HIV-Infected South African Adults. J. Acquir. Immune Defic. Syndr. 43(1):78-84.
Crossref

 

Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Cotton M, Maartens G (2009). Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J. Acquir. Immune Defic. Syndr. 51(1):65-71.
Crossref

 

Nekemte Town Administration (2016). Socio-demographic profile of Nekemte town, 2016 (Unpublished). 

View

 

Obirikorang C, Selleh PK, Abledu JK, Fofie CO (2013). Predictors of adherence to antiretroviral therapy among HIV/AIDS patients in the upper west region of Ghana. AIDS 2013:1-7.
Crossref

 

ONUSIDA (2013). Rapport mondial, Rapport ONUSIDA surl'épidémiemondiale de sida, Genève. 

View

 

ONUSIDA (2014). SIDA: Vers une issue heureuse de la lutte contre le sida.

View

 

Pennap GR, Abdullahi U, Bako IA (2013). Adherence to highly active antiretroviral therapy and its challenges in people living with human immunodeficiency virus (HIV) infection in Keffi, Nigeria. J. AIDS HIV Res. 5:52-58.

 

Rabkin M, El-Sadr W, Abrams E (2003). The MTCT-Plus clinical manual. Mailman School of Public Health Columbia University.

View

 

Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen J (2010). Prevalence and interactions of patient-related risks for non-adherence to antiretroviral therapy among perinatally infected youth in the United States. AIDS Patient Care STDS 24(2):97-104.
Crossref

 

Sherr L, Lampe FC, Clucas C, Johnson M, Fisher M, Leake Date H, Anderson J, Edwards S, Smith CJ, Hill T, Harding R (2010). Self-reported non-adherence to ART and virological outcome in a multi-clinic UK study. AIDS Care 22(8):939-945.
Crossref

 

Suleiman IA, Momo A (2016). Adherence to antiretroviral therapy and its determinants among persons living with HIV/AIDS in Bayelsa state, Nigeria. Pharm. Pract. 14(1):631.
Crossref

 

Tadios Y, Davey G (2006). Antiretroviral treatment adherence and its correlates among people living with HIV/AIDS on highly active antiretroviral therapy in Addis Ababa, Ethiopia. Ethiop. Med. J. 44(3):237-44.

 

United Nations Programme on HIV and AIDS (UNAIDS) (2014). The gap report. 

View

 

Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R (2003). Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana. J. Acquir. Immune Defic. Syndr. 34(3):281-288.
Crossref

 

World Health Organization (WHO) (2015a). Health topics: Adolescent Health. 

View

 

World Health Organization (WHOb) (2015). HIV/AIDS: Treatment and care. 

View

 

Yaya I, Landoh DE, Saka B, Patchali PM, Wasswa P, Aboubakari AS, N'Dri MK, Patassi AA, Kombaté K, Pitche P (2014). Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS at the regional hospital of Sokodé, Togo. BMC Public Health 14:1308.
Crossref